See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2021_Ionis_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.7117152036785945, 'aggregate_val': 1839953000, 'exp_sum': 678520000, 'exp_to_value': {'LiabilitiesCurrent': 240550000, 'LiabilitiesNoncurrent': 351879000, 'remainder_Liabilities': 86091000}} |
Graph
Absolute values for 0000874015, Ionis Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,130,707,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 27,937,000 |
| 2 | PropertyPlantAndEquipmentNet | 181,077,000 |
| 3 | remainder_Assets | 50,034,000 |
| 4 | LiabilitiesCurrent | 583,250,000 |
| 5 | LiabilitiesNoncurrent | 424,046,000 |
| 6 | remainder_Liabilities | 539,112,000 |
| 7 | CostOfGoodsAndServicesSold | 49,746,442 |
| 8 | SellingGeneralAndAdministrativeExpense | 496,334,010 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 969,728,038 |
| 11 | remainder_Revenues | 834,885,030 |
| 12 | remainder_NetIncome | 42,393,122 |
| 13 | remainder_ComprehensiveNetIncome | 23,972,417 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,389,755,000 |
| 1 | Liabilities | 1,546,408,000 |
| 2 | Expenses | 1,515,808,490 |
| 3 | Revenues | 834,885,030 |
| 4 | StockholdersEquity | 843,347,000 |
| 5 | NetIncome | -638,530,338 |
| 6 | ComprehensiveNetIncome | -626,544,130 |
| 7 | BaseVar | 3,176,611,030 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.616 |
| 9 | EconomicCapitalRatio | 1.98 |
Edgar->Model Mapping
Feature Distribution
Change over Time
